Search

Clinical Articles / BY: Sophia Wong, MD, FRCPC September 2013
... the most common genetic metabolic disease of consequence.[ 4 ] An autosomal condition with complete penetrance, hFH ...
News April 2013
... is fore­cast to go up 2.3% in 2013–14, rising by 2.4% and 2.7% in the next two years as part of a 3-year plan. ... are getting the same in­crease as forecast last year, 4.3% and 2.9% respectively for 2013–2014 and 2014–2015, ... years. Starting 1 January 2014, MSP premiums will increase 4%, meaning families of three or more will pay $138.50 per ...
News November 2013
... the Arthritis Society announced the commitment of over $4.5 million in funding for arthritis research projects in ...
Clinical Articles / BY: Romayne Gallagher, MD, CCFP(PC), FCFP March 2013
... which predispose them to both acute and chronic pain.[ 4 ]  Unrelieved pain has a profound effect on the gait and ... long-acting opioid or a short-acting opioid given every 4 hours should be added to the resident’s regimen and ...
Clinical Articles / BY: Hans Krueger, PhD, July/August 2013
... opinion that screening be initiated at the age of 21.”[ 4 ]  A review of the literature suggests four reasons for ... and precancerous lesions common in younger women, and (4) the likely harms associated with screening. Low incidence ... prominent with age: 7.5% in wo­men younger than 25, 12.4% in women 25 to 34, 13.7% in women 35 to 44, 15.7% in women ...
Clinical Articles / BY: Tyler W. Smith, MD, MHSc, FRCPC April 2013
... antithrombin deficiencies remaining of uncertain value.[ 4-7 ]  More importantly, studies have yet to show any ... (9 or 10 of 11 respondents) for only 27% of the scenarios (4 of 15), partial agreement (8 of 11 respondents) for 40% of ... 1 , VGH received 7928 orders for FVL testing during the 4-year study period, most of which were for outpatients ...
BC Centre for Disease Control / BY: Monika Naus, MD, MHSc, FRCPC, FACPM October 2013
... to eggs such as hives without advance allergy testing.[ 4 ] LAIV is available in 10-dose cartons. Each dose is 0.2 mL ...
Letters / BY: Simon Moore, MD, CCFP January/February 2013
... is important because models exist (such as in Quebec[ 4 ]) where residents no longer work over 16 consecutive ...
BC Centre for Disease Control / BY: Mel Krajden, OBC, MD, FRCPC June 2013
... which accelerates HCV disease progression.[ 2-4 ] Stigma and dis­crimination adversely impact diagnosis ...
News March 2013
... The Selection Committee will accept nominations until 4 April 2013.  A letter of nomination including a current ...